Skip to main content
. Author manuscript; available in PMC: 2020 Jul 15.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2019 Mar 2;104(4):790–797. doi: 10.1016/j.ijrobp.2019.02.045

Figure 4: Cumulative Incidence of Prostate Cancer-Specific Mortality for the Entire Patient Cohort Treated to 70 Gy vs. 78 Gy.

Figure 4:

Cumulative incidence of prostate cancer-specific mortality at 15 and 20 years was significantly higher in the patients receiving 70 Gy (Blue Line; 6.2% and 10.2%, respectively) compared to 78 Gy (Red Line; 3.2% and 5.4%, respectively) (Subhazard Ratio [sHR] 0.52, 95% Confidence Interval [CI] 0.27 – 0.98; Fine-Gray P=0.045).